CTCF and acute lymphoblastic leukemia: Many of those mutations at key ZF residues are predicted to result in loss of function however it has been shown that R339Q (found in ALL and NDD) and L309P (found in ALL) in CTCF can result in gain-of-function phenotypes in cell growth assays (Bailey et al., 2021).